News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

National Institutes of Health (NIH) Awards Genitrix, LLC $850,000 For Opsonokine(TM) Technology



10/19/2005 5:11:40 PM

CAMBRIDGE, MA -- (MARKET WIRE) -- 07/20/2005 -- Genitrix, LLC announced today that it has received a grant of approximately $850,000 from the National Institutes of Health. The two-year, Phase II SBIR (Small Business Innovation Research) grant will be used to advance the development of the Company's lead Opsonokine (Tm) molecule.

Read at Market Wired


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES